Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

Objective: Panel-based sequencing is widely used to measure tumor mutational burden (TMB) in clinical trials and is ready to enter routine diagnostics. However, cut-off points to distinguish “TMB-high” from “TMB-low” tumors are not consistent and the clinical implications of TMB in predicting respon...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Kim, Jinchul, Kim, Binnari, Kang, So Young, Heo, You Jeong, Park, Se Hoon, Kim, Seung Tae, Kang, Won Ki, Lee, Jeeyun, Kim, Kyoung-Mee
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082319/
https://ncbi.nlm.nih.gov/pubmed/32232003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00314
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker